相关实验视频
Updated: Sep 20, 2025

The CYP2D6 Animal Model: How to Induce Autoimmune Hepatitis in Mice
Published on: February 3, 2012
细胞外的异素诱导B细胞中的无能,以缓解自身免疫性肝炎
Nana Cui1, Qiwei Qian1, Yujie Zhou1
1Division of Gastroenterology and Hepatology, Key Laboratory of Gastroenterology and Hepatology, Ministry of Health, State Key Laboratory for Oncogenes and Related Genes, NHC Key Laboratory of Digestive Diseases, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai Institute of Digestive Disease, Shanghai, China.
它的代谢物伊诺辛通过扩大无性B细胞和抑制抗体分泌细胞来促进B细胞耐受性,这为自身免疫性肝炎提供了潜在的治疗方法.
科学领域:
- 免疫学 免疫学 免疫学
- 代谢过程中的代谢.
- 自免疫性疾病 自免疫性疾病
背景情况:
- 不调节的B细胞受体 (BCR) 信号和抗体分泌细胞 (ASC) 生成与自身免疫性疾病有关.
- 无能B细胞 (BNDs),具有较低表面IgM-BCR的特征,表现出减少的自身抗原反应.
- 在自身免疫性肝炎 (AIH) 中B细胞无能性的调节机制尚不清楚.
研究的目的:
- 研究B细胞无能和纯能代谢在AIH中的作用.
- 探索伊诺辛作为AIH的潜在治疗剂.
主要方法:
- 流细胞计分析AIH患者和小鼠模型中的B细胞子集.
- 在体外分化人类B细胞与氨酸或抑制剂.
- 使用ENT1抑制剂进行的qPCR,西式涂抹和体内研究.
主要成果:
- 艾滋病患者的ASC增加,BNDs降低.
- BNDs表达了高水平的CD73,参与纯能代谢.
- 伊诺辛治疗扩大了BNDs,并通过ENT1和PARP14-STAT6通路抑制了ASC分化.
结论:
- 伊诺是诱导B细胞免疫耐受性的关键代谢物.
- 伊诺辛代表了AIH的潜在治疗策略.
相关概念视频
B Cell Activation and Differentiation
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
Autoimmune Disorders
Concept and Mechanism of Autoimmune Diseases
The immune...
Special Features of Adaptive Immunity
The primary cell types involved in adaptive immunity are T cells and B cells. Each type has a unique role in defending the body against pathogens. T cells are responsible for cell-mediated immunity. They identify and eliminate infected cells directly,...
Allergic Drug Reactions
Immune Response Against Viral Pathogens
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
Myasthenia Gravis: Overview and Treatment
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...

